Johanna Mylet
Director of Finance/CFO chez POSEIDA THERAPEUTICS, INC.
Fortune : 785 643 $ au 31/03/2024
Profil
Johanna M.
Mylet is currently the Chief Financial Officer at Poseida Therapeutics, Inc. She started this position in 2021.
Prior to her current role, she worked as a Controller at HUYA Bioscience International LLC from 2014 to 2015.
Before that, she served as an Audit Manager at Grant Thornton LLP from 2008 to 2014.
Ms. Mylet completed her undergraduate degree at the University of San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 246 283 ( 0,26% ) | 785 643 $ | 31/03/2024 |
Postes actifs de Johanna Mylet
| Sociétés | Poste | Début |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director of Finance/CFO | 01/07/2020 |
Anciens postes connus de Johanna Mylet
| Sociétés | Poste | Fin |
|---|---|---|
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 01/06/2015 |
Grant Thornton LLP
 Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | 01/04/2014 |
Formation de Johanna Mylet
| University of San Diego | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL. | Commercial Services |
